News

CAE (CAE) came out with quarterly earnings of $0.15 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.15 per share a year ago. These figures are adjusted for

Beyond Air, Inc. (XAIR) came out with a quarterly loss of $1.53 per share versus the Zacks Consensus Estimate of a loss of $1.5. This compares to a loss of $5.4 per share a year ago. These figures

Webtoon Entertainment (WBTN) came out with quarterly earnings of $0.07 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to earnings of $0.2 per share a year ago

Alico (ALCO) came out with a quarterly loss of $2.39 per share versus the Zacks Consensus Estimate of a loss of $1.09. This compares to a loss of $0.27 per share a year ago. These figures are

PSQ Holdings, Inc. (PSQH) came out with a quarterly loss of $0.18 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to a loss of $0.28 per share a year ago. These

Generation Bio Co. (GBIO) came out with a quarterly loss of $3.12 per share versus the Zacks Consensus Estimate of a loss of $2.8. This compares to a loss of $3.1 per share a year ago. These figures

Pixelworks (PXLW) came out with a quarterly loss of $1 per share versus the Zacks Consensus Estimate of a loss of $1.08. This compares to a loss of $1.56 per share a year ago. These figures are

Investors in Ashland Inc. ASH need to pay close attention to the stock based on moves in the options market lately. That is because the Oct. 17, 2025 $40 Callhad some of the highest implied

NeuroPace, Inc. (NPCE) came out with a quarterly loss of $0.26 per share versus the Zacks Consensus Estimate of a loss of $0.24. This compares to a loss of $0.26 per share a year ago. These figures

Theravance Biopharma (TBPH) came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of a loss of $0.14. This compares to a loss of $0.13 per share a year ago. These

Surf Air Mobility Inc. (SRFM) came out with a quarterly loss of $0.93 per share versus the Zacks Consensus Estimate of a loss of $1.09. This compares to a loss of $1.96 per share a year ago. These

Luminar Technologies, Inc. (LAZR) came out with a quarterly loss of $1.49 per share versus the Zacks Consensus Estimate of a loss of $1.19. This compares to a loss of $2.7 per share a year ago

GCT Semiconductor Holding, Inc. (GCTS) came out with a quarterly loss of $0.26 per share versus the Zacks Consensus Estimate of a loss of $0.14. This compares to a loss of $0.02 per share a year

Verrica Pharmaceuticals Inc. (VRCA) came out with quarterly earnings of $0.02 per share, beating the Zacks Consensus Estimate of a loss of $0.7 per share. This compares to a loss of $3.1 per share a

Absci Corporation (ABSI) came out with a quarterly loss of $0.24 per share versus the Zacks Consensus Estimate of a loss of $0.19. This compares to a loss of $0.22 per share a year ago. These

Lyra Therapeutics, Inc. (LYRA) came out with a quarterly loss of $5.51 per share versus the Zacks Consensus Estimate of a loss of $5.79. This compares to a loss of $14.5 per share a year ago. These

Intapp (INTA) came out with quarterly earnings of $0.27 per share, beating the Zacks Consensus Estimate of $0.23 per share. This compares to earnings of $0.15 per share a year ago. These figures are

Intellicheck Mobilisa, Inc. (IDN) came out with a quarterly loss of $0.01 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.01 per share a year ago. These figures

Fate Therapeutics (FATE) came out with a quarterly loss of $0.29 per share versus the Zacks Consensus Estimate of a loss of $0.35. This compares to a loss of $0.33 per share a year ago. These

Editas Medicine (EDIT) came out with a quarterly loss of $0.63 per share versus the Zacks Consensus Estimate of a loss of $0.41. This compares to a loss of $0.82 per share a year ago. These figures

Lumentum (LITE) came out with quarterly earnings of $0.88 per share, beating the Zacks Consensus Estimate of $0.82 per share. This compares to earnings of $0.06 per share a year ago. These figures

Journey Medical Corporation (DERM) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to a loss of $0.17 per share a year ago

Lineage Cell (LCTX) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to a loss of $0.03 per share a year ago. These figures are

Cue Biopharma, Inc. (CUE) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to a loss of $0.2 per share a year ago. These